Literature DB >> 24767805

The ALPPS procedure for hepatocellular carcinoma.

G Vennarecci1, A Laurenzi2, G B Levi Sandri2, E Busi Rizzi3, M Cristofaro3, M Montalbano4, P Piselli5, A Andreoli6, G D'Offizi4, G M Ettorre2.   

Abstract

BACKGROUND: The main limiting factor to major hepatic resections is the amount of the future liver remnant (FLR). Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) is a procedure which induces a rapid hypertrophy of the FLR in patients with non-resectable liver tumours.
METHODS: ALPPS is a surgical technique of in-situ splitting of the liver along the main portal scissura or the right side of the falciform ligament, in association with portal vein ligation in order to induce a rapid hypertrophy of the left FLR.
RESULTS: The median FLR volume increase was 18.7% within one week after the first step and 38.6% after the second step. At the first step the median operating time was 300 min, blood transfusions were not required in any case, median blood loss was 150 cc. At the second step median operating time was 180 min, median blood loss was 50 cc, none of the patients required intra-operative blood. All patients are alive at a median follow up of 9 months.
CONCLUSIONS: This novel strategy seems to be feasible even in the context of a cirrhotic liver, and demonstrates the capacity to reach a sufficient FLR within a shorter interval of time.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALPPS; HCC; Liver resection; Portal vein embolisation; Two stage hepatectomy

Mesh:

Year:  2014        PMID: 24767805     DOI: 10.1016/j.ejso.2014.04.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  19 in total

Review 1.  Post-hepatectomy liver failure.

Authors:  Rondi Kauffmann; Yuman Fong
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery.

Authors:  Qiang Gao; Xiao-Ying Wang; Jian Zhou; Jia Fan
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

3.  Associating liver partition and portal vein ligation for bleeding hepatocellular carcinoma in HBV cirrhosis: a safety strategy.

Authors:  Giovanni Battista Levi Sandri; Giovanni Vennarecci; Pasquale Lepiane; Giuseppe Maria Ettorre
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-23

4.  Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012-2014.

Authors:  Matteo Serenari; Matteo Zanello; Erik Schadde; Elena Toschi; Francesca Ratti; Enrico Gringeri; Michele Masetti; Umberto Cillo; Luca Aldrighetti; Elio Jovine
Journal:  HPB (Oxford)       Date:  2016-03-13       Impact factor: 3.647

Review 5.  Associated liver partition and portal vein ligation for staged hepatectomy: a review.

Authors:  Kai Siang Chan; Jee Keem Low; Vishal G Shelat
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 6.  Laparoscopic and robotic approach for hepatocellular carcinoma-state of the art.

Authors:  Giovanni Battista Levi Sandri; Edoardo de Werra; Gianluca Mascianà; Marco Colasanti; Roberto Santoro; Vito D'Andrea; Giuseppe Maria Ettorre
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 7.  Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).

Authors:  Hui-Chuan Sun; Jian Zhou; Zheng Wang; Xiufeng Liu; Qing Xie; Weidong Jia; Ming Zhao; Xinyu Bi; Gong Li; Xueli Bai; Yuan Ji; Li Xu; Xiao-Dong Zhu; Dousheng Bai; Yajin Chen; Yongjun Chen; Chaoliu Dai; Rongping Guo; Wenzhi Guo; Chunyi Hao; Tao Huang; Zhiyong Huang; Deyu Li; Gang Li; Tao Li; Xiangcheng Li; Guangming Li; Xiao Liang; Jingfeng Liu; Fubao Liu; Shichun Lu; Zheng Lu; Weifu Lv; Yilei Mao; Guoliang Shao; Yinghong Shi; Tianqiang Song; Guang Tan; Yunqiang Tang; Kaishan Tao; Chidan Wan; Guangyi Wang; Lu Wang; Shunxiang Wang; Tianfu Wen; Baocai Xing; Bangde Xiang; Sheng Yan; Dinghua Yang; Guowen Yin; Tao Yin; Zhenyu Yin; Zhengping Yu; Bixiang Zhang; Jialin Zhang; Shuijun Zhang; Ti Zhang; Yamin Zhang; Yubao Zhang; Aibin Zhang; Haitao Zhao; Ledu Zhou; Wu Zhang; Zhenyu Zhu; Shukui Qin; Feng Shen; Xiujun Cai; Gaojun Teng; Jianqiang Cai; Minshan Chen; Qiang Li; Lianxin Liu; Weilin Wang; Tingbo Liang; Jiahong Dong; Xiaoping Chen; Xuehao Wang; Shusen Zheng; Jia Fan
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

Review 8.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

Review 9.  Strategies to increase the resectability of hepatocellular carcinoma.

Authors:  Wong Hoi She; Kenneth Sh Chok
Journal:  World J Hepatol       Date:  2015-08-28

Review 10.  Preoperative portal vein embolization for hepatocellular carcinoma: Consensus and controversy.

Authors:  Taku Aoki; Keiichi Kubota
Journal:  World J Hepatol       Date:  2016-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.